NEW YORK (GenomeWeb News) – Life Technologies and Fluidigm were among tool vendors and academic research groups that were awarded funding last week from the California Institute for Regenerative Medicine to support the development of tools and reagents for stem cell research.
 
Life Technologies said that it would use a grant of around $870,000 from CIRM to develop disease models of Lou Gehrig’s disease and other neurodegenerative conditions from human embryonic stem cells.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.